Active Startup: Nanora Pharma USA

News

Published: 9Oct2019

Business Snapshot
Develop a polymeric nano-delivery vehicle for therapeutics like small interfering RNA (siRNA), pDNA (plasmid DNA), shRNA (short hairpin RNA), antisense oligonucleotides (ASOs), chemotherapeutic drugs and small molecules. The delivery vehicle developed (NORAfecta) is a platform technology that can cater its suitability towards different applications, such as targeting cancer and neurodegenerative diseases.

Target Markets
Cancer, CNS disorders.

Intellectual Property
In prosecution in the US and Canada.

Founder
Satya Prakash